4.6 Review

Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS

Journal

CURRENT MEDICINAL CHEMISTRY
Volume 30, Issue 12, Pages 1406-1419

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867329666220906111550

Keywords

ARDS; COVID-19; inflammasome; inhibitors; NLRP3; SARS-CoV-2

Ask authors/readers for more resources

Given the significance of COVID-19-induced ARDS, researchers have recently focused on identifying the underlying mechanisms of inflammatory responses. Inflammasomes play a crucial role in cytokine storm development and subsequent ARDS progression in patients with SARS-CoV-2 infection. This mini-review provides a comprehensive analysis of known inflammasome inhibitors and ongoing research in this field.
Given the importance of COVID-19-induced ARDS, recently, researchers have strived to determine underlying mechanisms involved in the inflammatory responses. In this regard, inflammasomes possess a distinct priority for cytokine storm occurrence and, subsequently, ARDS progression in ill patients with SARS-CoV-2 infection. In this mini-review, the characteristics of known inflammasome inhibitors and designed research in this field were concretely deciphered.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available